Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Research Article

Factors Influencing Hypoglycemia in Type 2 Diabetes Mellitus Outpatients with State Health Insurance at Regional General Hospitals in Jakarta, Indonesia

In Press, (this is not the final "Version of Record"). Available online 11 January, 2024
Author(s): Putu Rika Veryanti, Rani Sauriasari*, Ratu Ayu Dewi Sartika and Berna Elya
Published on: 11 January, 2024

Article ID: e110124225530

DOI: 10.2174/0115733998280552231228064154

Price: $95

Abstract

Background: Hypoglycemia is an acute episode that can lead to death in patients with diabetes mellitus (DM). This condition is preventable with patient education, and identifying factors influencing their occurrence is essential to creating effective and efficient education. It also leads to prevention and control by re-organizing the service system and diabetes policies. This study aimed to determine factors contributing to hypoglycemic episodes in type 2 DM outpatients covered by the state-provided Jaminan Kesehatan Nasional (JKN) health insurance.

Methods: The study used a cross-sectional design and collected data from five regional general hospitals in Jakarta, Indonesia. The outpatients were sampled consecutively from two hospitals in September–November 2021, one in January–March 2022, and two others in April–June 2023. Interviews produced primary data related to experienced hypoglycemic episodes, and medical records provided secondary data on patients' clinical characteristics and treatments. Binary logistic regression analysis was employed to process the contributing factors statistically.

Results: From 501 patients who met the inclusion and exclusion criteria, it was found that the prevalence of hypoglycemia was 53.3%. Factors that significantly increased hypoglycemic risk (p < 0.05) were high HbA1C levels (OR 1.9; 95% CI 1.2–2.9), comorbidities (OR 1.6; 95% CI 1.1–2.4), insulin/sulfonylurea therapy (OR 2; 95% CI 1–4), non-smoking habit (OR 2.2; 95% CI 1.3–3.6) and physically active lifestyle (OR 1.8; 95% CI 1.2–2.6).

Conclusion: The prevalence of hypoglycemia in type 2 diabetes mellitus (DM) outpatients with the state-provided health insurance Jaminan Kesehatan Nasional (JKN) at general hospitals in Jakarta is high. The diabetes self-management education (DSME) services provided by health professionals for these outpatients must be further improved.

[1]
Diabetes Atlas IDF IDF Diabetes Atlas 2021.
[2]
Indonesian Ministry of Health National Health Research Report. Jakarta 2019.
[3]
Alkaff FF, Illavi F, Salamah S, et al. The impact of the indonesian chronic disease management program (PROLANIS) on metabolic control and renal function of type 2 diabetes mellitus patients in primary care setting. J Prim Care Community Health 2021; 12.
[http://dx.doi.org/10.1177/2150132720984409] [PMID: 33472499]
[4]
Khoe LC, Wangge G, Soewondo P, Tahapary DL, Widyahening IS. The implementation of community-based diabetes and hypertension management care program in Indonesia. PLoS One 2020; 15(1): e0227806.
[http://dx.doi.org/10.1371/journal.pone.0227806] [PMID: 31935256]
[5]
Indonesian Ministry of Health. Decree of the Minister of Health Number HK In: 0107/MENKES/6485/2021 on the National Formulary. 2021.
[6]
Indonesian endocrinology association guidelines for the management and prevention of type 2 diabetes mellitus in adults in Indonesia. PB Perkeni 2021.
[7]
Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the american diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care 2018; 41(12): 2669-701.
[http://dx.doi.org/10.2337/dci18-0033] [PMID: 30291106]
[8]
Annisa BS, Puspitasari CE, Aini SR. Profil penggunaan obat antidiabetes pada pasien diabetes mellitus tipe 2 di instalasi rawat jalan RSUD Provinsi NTB tahun 2018. Sasambo J Pharm 2021; 2(1): 37-41.
[http://dx.doi.org/10.29303/sjp.v2i1.74]
[9]
Binti Sappo N, Rahmawati D, Ramadhan AM. Pharmaceutical research and development L, tropis F. characteristics and patterns of anti-diabetic drug use in type 2 diabetes mellitus patients at Abdul Wahab Sjarahranie Regional Hospital. Proceeding of Mulawarman Pharmaceuticals Conferences. 41-7.
[10]
Eroglu N, Sabuncu N. The effect of education given to type 2 diabetic individuals on diabetes self-management and self-efficacy: Randomized controlled trial. Prim Care Diabetes 2021; 15(3): 451-8.
[http://dx.doi.org/10.1016/j.pcd.2021.02.011] [PMID: 33674221]
[11]
Norris S, Nichols P, Caspersen C, et al. Increasing diabetes self-management education in community settings a systematic review. Am J Prev Med 2002; 22(4) (Suppl.): 39-66.
[http://dx.doi.org/10.1016/S0749-3797(02)00424-5] [PMID: 11985934]
[12]
Greenway FL. Severe hypoglycemia in the look ahead trial. J Diabetes Complications 2016; 30(5): 935-43.
[http://dx.doi.org/10.1016/j.jdiacomp.2016.03.016] [PMID: 27114389]
[13]
Iloh GP, Amadi A. Epidemiology of hypoglycemia among ambulatory Type 2 diabetic patients in a primary care clinic of a tertiary hospital in Southeastern Nigeria. J Health Res Rev 2018; 5(2): 57.
[http://dx.doi.org/10.4103/jhrr.jhrr_37_17]
[14]
Shriraam V, Mahadevan S, Anitharani M, et al. Reported hypoglycemia in Type 2 diabetes mellitus patients: Prevalence and practices-a hospital-based study. Indian J Endocrinol Metab 2017; 21(1): 148-53.
[http://dx.doi.org/10.4103/2230-8210.196002] [PMID: 28217515]
[15]
Snell-Bergeon JK, Wadwa RP. Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol Ther 2012; 14(S1) (Suppl. 1): S-51-8.
[http://dx.doi.org/10.1089/dia.2012.0031] [PMID: 22650225]
[16]
Morales J, Schneider D. Hypoglycemia. Am J Med 2014; 127(10) (Suppl.): S17-24.
[http://dx.doi.org/10.1016/j.amjmed.2014.07.004] [PMID: 25282009]
[17]
Besen DB, Surucu HA, Koşar C. Self-reported frequency, severity of, and awareness of hypoglycemia in type 2 diabetes patients in Turkey PeerJ 2016; 2016
[18]
van Meijel LA, de Vegt F, Abbink EJ, et al. High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The dutch diabetes pearl cohort. BMJ Open Diabetes Res Care 2020; 8(1): e000935.
[http://dx.doi.org/10.1136/bmjdrc-2019-000935] [PMID: 32107264]
[19]
Hussein Z, Kamaruddin NA, Chan SP, Jain A, Uppal S, Bebakar WMW. Hypoglycemia awareness among insulin-treated patients with diabetes in Malaysia: A cohort subanalysis of the HAT study. Diabetes Res Clin Pract 2017; 133: 40-9.
[http://dx.doi.org/10.1016/j.diabres.2017.08.007] [PMID: 28888148]
[20]
Bain A, Kavanagh S, McCarthy S, Babar ZUD. Assessment of insulin-related knowledge among healthcare professionals in a large teaching hospital in the united kingdom. Pharmacy 2019; 7(1): 16.
[http://dx.doi.org/10.3390/pharmacy7010016] [PMID: 30704103]
[21]
Rezende PC, Everett BM, Brooks MM, et al. Hypoglycemia and elevated troponin in patients with diabetes and coronary artery disease. J Am Coll Cardiol 2018; 72(15): 1778-86.
[http://dx.doi.org/10.1016/j.jacc.2018.07.067] [PMID: 30286920]
[22]
Heller SR, Geybels MS, Iqbal A, Liu L, Wagner L, Chow E. A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study. Diabetologia 2021.
[PMID: 34704120]
[23]
Echouffo-Tcheugui JB, Daya N, Lee AK, et al. Severe hypoglycemia, cardiac structure and function, and risk of cardiovascular events among older adults with diabetes. Diabetes Care 2021; 44(1): 248-54.
[http://dx.doi.org/10.2337/dc20-0552] [PMID: 33199469]
[24]
Quilliam BJ, Simeone JC, Ozbay AB, Kogut SJ. The incidence and costs of hypoglycemia in type 2 diabetes. Am J Manag Care 2011; 17(10): 673-80.
[PMID: 22106460]
[25]
Aljunid SM, Aung YN, Ismail A, et al. Economic burden of hypoglycemia for type II diabetes mellitus patients in Malaysia. PLoS One 2019; 14(10): e0211248.
[http://dx.doi.org/10.1371/journal.pone.0211248] [PMID: 31652253]
[26]
Strizek A, Chang CJ, Furnback W, Wang B, Lebrec J, Lew T. The cost of hypoglycemia associated with type 2 diabetes mellitus in Taiwan. Value Health Reg Issues 2019; 18: 84-90.
[http://dx.doi.org/10.1016/j.vhri.2019.01.002] [PMID: 30776767]
[27]
Hidayat B, Ramadani RV, Rudijanto A, Soewondo P, Suastika K, Siu Ng JY. Direct medical cost of type 2 diabetes mellitus and its associated complications in Indonesia. Value Health Reg Issues 2022; 28: 82-9.
[http://dx.doi.org/10.1016/j.vhri.2021.04.006] [PMID: 34839111]
[28]
Hall TA. Designing culturally relevant educational materials for Mexican American clients. Diabetes Educ 1987; 13(3): 281-5.
[http://dx.doi.org/10.1177/014572178701300308] [PMID: 3665715]
[29]
Park JS, Ahn CW. Educational program for diabetic patients in Korea—Multidisplinary intensive management. Diabetes Res Clin Pract 2007; 77(3) (Suppl. 1): S194-8.
[http://dx.doi.org/10.1016/j.diabres.2007.01.056] [PMID: 17448562]
[30]
LaManna J, Litchman ML, Dickinson JK, et al. Diabetes education impact on hypoglycemia outcomes: A systematic review of evidence and gaps in the literature. Diabetes Educ 2019; 45(4): 349-69.
[http://dx.doi.org/10.1177/0145721719855931] [PMID: 31210091]
[31]
Rudijanto A, Saraswati MR, Yunir E, Kumala P, Puteri HHS, Mandang VVV. Indonesia cohort of IO HAT study to evaluate diabetes management, control, and complications in retrospective and prospective periods among insulin-treated patients with type 1 and type 2 diabetes. Acta Med Indones 2018; 50(1): 26-37.
[PMID: 29686173]
[32]
Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013; 36(5): 1384-95.
[http://dx.doi.org/10.2337/dc12-2480] [PMID: 23589542]
[33]
Rickels MR. Hypoglycemia‐associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes. Ann N Y Acad Sci 2019; 1454(1): 68-79.
[http://dx.doi.org/10.1111/nyas.14214] [PMID: 31389033]
[34]
Mohseni M, Ahmadi S, Azami-Aghdash S, et al. Challenges of routine diabetes care during COVID-19 era: A systematic search and narrative review. Prim Care Diabetes 2021; 15(6): 918-22.
[http://dx.doi.org/10.1016/j.pcd.2021.07.017] [PMID: 34393092]
[35]
Parkin CG, Davidson JA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol 2009; 3(3): 500-8.
[http://dx.doi.org/10.1177/193229680900300314] [PMID: 20144288]
[36]
Klonoff DC. The current status of Health for diabetes: Will it be the next big thing? J Diabetes Sci Technol 2013; 7(3): 749-58.
[http://dx.doi.org/10.1177/193229681300700321] [PMID: 23759409]
[37]
Kacheva S, Karges B, Göller K, Marx N, Mischke K, Karges W. QT prolongation caused by insulin-induced hypoglycaemia – An interventional study in 119 individuals. Diabetes Res Clin Pract 2017; 123: 165-72.
[http://dx.doi.org/10.1016/j.diabres.2016.11.021] [PMID: 28024277]
[38]
Pearson SM, Whittam B, Kulavarasalingam K, Mitchell-Gears A, James C, Ajjan RA. Reduction in cardiovascular mortality following severe hypoglycemia in individuals with type 2 diabetes: The role of a pragmatic and structured intervention. Cardiovasc Diabetol 2021; 20(1): 18.
[http://dx.doi.org/10.1186/s12933-020-01204-3] [PMID: 33435992]
[39]
Lamounier RN, Geloneze B, Leite SO, et al. Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: The HAT study in Brazil. Diabetol Metab Syndr 2018; 10(1): 83.
[http://dx.doi.org/10.1186/s13098-018-0379-5] [PMID: 30479669]
[40]
Borzì V, Frasson S, Gussoni G, et al. Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND study. Diabetes Res Clin Pract 2016; 115: 24-30.
[http://dx.doi.org/10.1016/j.diabres.2016.01.020] [PMID: 27242119]
[41]
Avari P, Moscardo V, Jugnee N, Oliver N, Reddy M. Glycemic variability and hypoglycemic excursions with continuous glucose monitoring compared to intermittently scanned continuous glucose monitoring in adults with highest risk type 1 diabetes. J Diabetes Sci Technol 2020; 14(3): 567-74.
[http://dx.doi.org/10.1177/1932296819867688] [PMID: 31375042]
[42]
Malkani S, Kotwal A. Frequency and predictors of self-reported hypoglycemia in insulin-treated diabetes. J Diabetes Res 2017; 2017
[43]
Lee AK, Lee CJ, Huang ES, Sharrett AR, Coresh J, Selvin E. Risk factors for severe hypoglycemia in black and white adults with diabetes: The atherosclerosis risk in communities (ARIC) study. Diabetes Care 2017; 40(12): 1661-7.
[http://dx.doi.org/10.2337/dc17-0819] [PMID: 28928117]
[44]
Akirov A, Amitai O, Masri-Iraqi H, et al. Predictors of hypoglycemia in hospitalized patients with diabetes mellitus. Intern Emerg Med 2018; 13(3): 343-50.
[http://dx.doi.org/10.1007/s11739-018-1787-0] [PMID: 29340912]
[45]
Au NH, Ratzki-Leewing A, Zou G, Ryan BL, Webster-Bogaert S, Reichert SM, et al. Real-world incidence and risk factors for daytime and nocturnal non-severe hypoglycemia in adults with type 2 diabetes mellitus on insulin and/or secretagogues (InHypo-DM Study, Canada). Can J Diabetes 2021.
[PMID: 35288040]
[46]
Nuzzo A, Brignoli A, Chantal Ponziani M, Zavattaro M, Prodam F, Castello LM, et al. Aging and comorbidities influence the risk of hospitalization and mortality in diabetic patients experiencing severe hypoglycemia. Nutr Metab Cardiovasc Dis 2021.
[PMID: 34802847]
[47]
Lv X, Fang K, Hao W, Han Y, Yang N, Yu Q. Identification of reactive hypoglycemia with different basic bmi and its causes by prolonged oral glucose tolerance test. Diabetes Metab Syndr Obes 2020; 13: 4717-26.
[http://dx.doi.org/10.2147/DMSO.S280084] [PMID: 33293845]
[48]
Bie-Olsen LG, Pedersen-Bjergaard U, Kjær TW, Lonsdale MN, Law I, Thorsteinsson B. Differences in cortical and pituitary activity in response to hypoglycaemia and cognitive testing in healthy men with different basal activity of the renin-angiotensin system. J Renin Angiotensin Aldosterone Syst 2010; 11(3): 173-9.
[http://dx.doi.org/10.1177/1470320310364182] [PMID: 20215476]
[49]
Ensling M, Steinmann W, Whaley-Connell A. Hypoglycemia: A possible link between insulin resistance, metabolic dyslipidemia, and heart and kidney disease (the Cardiorenal Syndrome). Cardiorenal Med 2011; 1(1): 67-74.
[http://dx.doi.org/10.1159/000322886] [PMID: 22258467]
[50]
Pratiwi C, Mokoagow MI, Made Kshanti IA, Soewondo P. The risk factors of inpatient hypoglycemia: A systematic review. Heliyon 2020; 6(5): e03913.
[http://dx.doi.org/10.1016/j.heliyon.2020.e03913] [PMID: 32420485]
[51]
Ray CY, Wu VCC, Wang CL, et al. Hypoglycemia associated with drug–drug interactions in patients with type 2 diabetes mellitus using dipeptidylpeptidase-4 inhibitors. Front Pharmacol 2021; 12: 570835.
[http://dx.doi.org/10.3389/fphar.2021.570835] [PMID: 34040513]
[52]
Romley JA, Gong C, Jena AB, Goldman DP, Williams B, Peters A. Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: Retrospective cohort analysis. BMJ 2015; 351: h6223.
[http://dx.doi.org/10.1136/bmj.h6223] [PMID: 26643108]
[53]
Thamer M, Ray NF, Taylor T. Association between antihypertensive drug use and hypoglycemia: A case-control study of diabetic users of insulin or sulfonylureas. Clin Ther 1999; 21(8): 1387-400.
[http://dx.doi.org/10.1016/S0149-2918(99)80039-3] [PMID: 10485510]
[54]
Parekh TM, Raji M, Lin YL, Tan A, Kuo YF, Goodwin JS. Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas. JAMA Intern Med 2014; 174(10): 1605-12.
[http://dx.doi.org/10.1001/jamainternmed.2014.3293] [PMID: 25179404]
[55]
Sonoda N, Morimoto A, Ugi S, et al. Predictors for mild and severe hypoglycemia in insulin-treated Japanese diabetic patients. PLoS One 2015; 10(6): e0130584.
[http://dx.doi.org/10.1371/journal.pone.0130584] [PMID: 26102197]
[56]
Nassar DT, Habib OS, Mansour AA. Predictors of hypoglycemia in insulin-treated patients with type 2 diabetes mellitus in Basrah. World J Diabetes 2016; 7(18): 470-80.
[http://dx.doi.org/10.4239/wjd.v7.i18.470] [PMID: 27795821]
[57]
Ajjan RA, Jackson N, Thomson SA. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial. Diab Vasc Dis Res 2019; 16(4): 385-95.
[http://dx.doi.org/10.1177/1479164119827456] [PMID: 31271312]
[58]
Cuddihy RM, Philis-Tsimikas A, Nazeri A. Type 2 diabetes care and insulin intensification: Is a more multidisciplinary approach needed? Results from the MODIFY survey. Diabetes Educ 2011; 37(1): 111-23.
[http://dx.doi.org/10.1177/0145721710388426] [PMID: 21131599]
[59]
Gómez-Huelgas R, Sabán-Ruiz J, García-Román FJ, et al. Safety and efficacy of a basal-plus regimen with insulin glargine and insulin glulisine for elderly patients with high cardiovascular risk and type 2 diabetes mellitus. Rev Clin Esp 2017; 217(4): 201-6.
[http://dx.doi.org/10.1016/j.rceng.2017.02.004] [PMID: 28314656]
[60]
Rados DV, Falcetta MRR, Pinto LC, Leitão CB, Gross JL. All-cause mortality and cardiovascular safety of basal insulin treatment in patients with type 2 diabetes mellitus: A systematic review with meta-analysis and trial sequential analysis. Diabetes Res Clin Pract 2021; 173: 108688.
[http://dx.doi.org/10.1016/j.diabres.2021.108688] [PMID: 33549676]
[61]
Mannucci E, Targher G, Nreu B, et al. Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2022; 32(6): 1353-60.
[http://dx.doi.org/10.1016/j.numecd.2022.03.007] [PMID: 35422359]
[62]
Li Z, Zhang Y, Quan X, et al. Efficacy and acceptability of glycemic control of glucagon-like peptide-1 receptor agonists among type 2 diabetes: A systematic review and network meta-analysis. PLoS One 2016; 11(5): e0154206.
[http://dx.doi.org/10.1371/journal.pone.0154206] [PMID: 27158818]
[63]
Xu X, Xu W, Zhuo Q, Yan Y. The efficacy and safety of dapagliflozin combined with oral hypoglycemic agents in patients with type 2 diabetes: A systematic review and meta-analysis. Ann Palliat Med 2022; 11(3): 1028-37.
[http://dx.doi.org/10.21037/apm-22-121] [PMID: 35365032]
[64]
Zhao JZ, Weinhandl ED, Carlson AM, St Peter WL. Hypoglycemia risk with SGLT2 inhibitors or glucagon-like peptide 1 receptor agonists versus sulfonylureas among medicare insured adults with CKD in the United States. Kidney Med 2022; 4(8): 100510.
[http://dx.doi.org/10.1016/j.xkme.2022.100510] [PMID: 35898692]
[65]
Sari MI, Sari N, Darlan DM, Prasetya RJ. Cigarette smoking and hyperglycaemia in diabetic patients. Open Access Maced J Med Sci 2018; 6(4): 634-7.
[http://dx.doi.org/10.3889/oamjms.2018.140] [PMID: 29731929]
[66]
Duarte CK, Almeida JC, Merker AJ, Brauer FdeO , Rodrigues TdaC . Physical activity level and exercise in patients with diabetes mellitus. Rev Assoc Med Bras 2012; 58(2): 215-21.
[PMID: 22569617]
[67]
Castonguay A, Miquelon P, Boudreau F. Self-regulation resources and physical activity participation among adults with type 2 diabetes. Health Psychol Open 2018; 5(1)
[http://dx.doi.org/10.1177/2055102917750331] [PMID: 29372066]
[68]
Zhu P, Pan XF, Sheng L, Chen H, Pan A. Cigarette smoking, diabetes, and diabetes complications: Call for urgent action. Curr Diab Rep 2017; 17(9): 78.
[http://dx.doi.org/10.1007/s11892-017-0903-2] [PMID: 28766247]
[69]
Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis 2003; 45(5): 405-13.
[http://dx.doi.org/10.1016/S0033-0620(03)80004-X] [PMID: 12704597]
[70]
Artese A, Stamford BA, Moffatt RJ. Cigarette smoking: An accessory to the development of insulin resistance. Am J Lifestyle Med 2019; 13(6): 602-5.
[http://dx.doi.org/10.1177/1559827617726516] [PMID: 31662726]
[71]
Campagna D, Alamo A, Di Pino A, Russo C, Calogero AE, Purrello F, et al. Smoking and diabetes: Dangerous liaisons and confusing relationships. Diabetol Metab 2019; 11: 1-12.
[http://dx.doi.org/10.1186/s13098-019-0482-2]
[72]
Maddatu J, Anderson-Baucum E, Evans-Molina C. Smoking and the risk of type 2 diabetes. Transl Res 2017; 184: 101-7.
[http://dx.doi.org/10.1016/j.trsl.2017.02.004] [PMID: 28336465]
[73]
Maideen NMP. Tobacco smoking and its drug interactions with comedications involving CYP and UGT enzymes and nicotine
[http://dx.doi.org/10.5497/wjp.v8.i2.14]
[74]
Porter JW, Pettit-Mee RJ, Ready ST, et al. Post meal exercise may lead to transient hypoglycemia irrespective of glycemic status in humans. Front Endocrinol 2020; 11: 578.
[http://dx.doi.org/10.3389/fendo.2020.00578] [PMID: 32982972]
[75]
Younk LM, Mikeladze M, Tate D, Davis SN. Exercise-related hypoglycemia in diabetes mellitus. Expert Rev Endocrinol Metab 2011; 6(1): 93-108.
[http://dx.doi.org/10.1586/eem.10.78] [PMID: 21339838]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy